We are live on ! Find out more
OP

Omni Partners Portfolio holdings

AUM $2.03B
1-Year Est. Return 126.33%
This Fund
S&P 500
This Quarter Est. Return
+15.53%
1 Year Est. Return
+126.33%
3 Year Est. Return
+411.65%
5 Year Est. Return
+1,549.93%
10 Year Est. Return
–
AUM
$3.73M
AUM Growth
-$1.38B
Cap. Flow
-$103M
Cap. Flow %
-2,765.76%
Top 10 Hldgs %
92.1%
Holding
54
New
24
Increased
5
Reduced
5
Closed
12

Top Buys

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$154M
2
TGE
Tallgrass Energy, LP Class A Shares
TGE
+$89.1M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$43.3M
4
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$37.1M
5
WMGI
Wright Medical Group Inc
WMGI
+$35.4M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$243M
2
CY
Cypress Semiconductor
CY
+$108M
3
VSM
Versum Materials, Inc.
VSM
+$99.7M
4
BPL
Buckeye Partners, L.P.
BPL
+$45.8M
5
MLNX
Mellanox Technologies, Ltd.
MLNX
+$38.8M

Sector Composition

Rank Sector Weight
1 Technology 37.07%
2 Healthcare 8.3%
3 Consumer Discretionary 4.6%
4 Energy 2.98%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NPAUU
26
DELISTED
New Providence Acquisition Corp. Unit
NPAUU
$7.71K 0.21%
750,000
– –
CIICU
27
DELISTED
CIIG Merger Corp. Units
CIICU
$7.62K 0.2%
+750,000
New +$7.61M
GSAH.U
28
DELISTED
GS Acquisition Holdings Corp. Units, each consisting of one share of Class A common stock and one-th
GSAH.U
$5.9K 0.16%
+500,000
New +$5.5M
FIT
29
DELISTED
Fitbit, Inc. Class A common stock
FIT
$5.14K 0.14%
+782,105
New +$4.59M
HPQ icon
30
HP
HPQ
$23.5B
$4.83K 0.13%
+234,922
New +$4.45M
XRX icon
31
Xerox
XRX
$337M
$4.52K 0.12%
+122,624
New +$4.29M
LPRO
32
Open Lending Corp
LPRO
$373M
$3.77K 0.1%
+358,100
New +$3.69M
BMY icon
33
Bristol-Myers Squibb
BMY
$127B
$2.56K 0.07%
+39,901
New +$2.29M
QGEN icon
34
Qiagen
QGEN
$8.53B
$2.34K 0.06%
+65,302
New +$2.43M
EMWP
35
DELISTED
Eros Media World PLC
EMWP
$2.06K 0.06%
+30,425
New +$1.42M
SAQNU
36
DELISTED
Software Acquisition Group Inc. Unit
SAQNU
$2.03K 0.05%
+200,000
New +$2.02M
BMY.RT
37
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1.75K 0.05%
+581,704
New +$1.51M
GCVRZ
38
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$1.24K 0.03%
+1,446,247
New +$1.11M
TRNE.WS
39
DELISTED
Trine Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A
TRNE.WS
$1.17K 0.03%
1,233,159
– –
NEBUU
40
DELISTED
Nebula Acquisition Corporation Unit
NEBUU
$540 0.01%
+50,000
New +$531K
PACQW
41
DELISTED
Pure Acquisition Corp. Warrant
PACQW
$527 0.01%
534,560
– –
LN
42
DELISTED
LINE Corporation
LN
$307 0.01%
+6,268
New +$268K
TDAY
43
USA Today Co
TDAY
$1.23B
– –
-137,756
Closed -$1.21M
GEN icon
44
CALL
Gen Digital
GEN
$15.6B
– –
-5,089
Closed -$12M
MPC icon
45
Marathon Petroleum
MPC
$90.3B
– –
-35,000
Closed -$2.13M
CPE
46
DELISTED
Callon Petroleum Company
CPE
– –
-369,735
Closed -$16M
BRMK
47
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
– –
-724,975
Closed -$7.57M
MGLN
48
DELISTED
Magellan Health Services, Inc.
MGLN
– –
-230,500
Closed -$14.3M
GWR
49
DELISTED
Genesee & Wyoming Inc.
GWR
– –
-168,100
Closed -$18.6M
PVT
50
DELISTED
Pivotal Acquisition Corp.
PVT
– –
-1,779,319
Closed -$18.1M
1
2
3

Similar funds

BUB
BBVA USA Bancshares Houston, Texas $2.1B AUM 62.57% 1-Year Est. Return
PAG
Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return
SBSB
Sullivan, Bruyette, Speros & Blaney Mclean, Virginia $2.27B AUM 50.71% 1-Year Est. Return
PPCM
Pillar Pacific Capital Management Pacifica, California $1.29B AUM 80.18% 1-Year Est. Return
AAM
Anglepoint Asset Management George Town, Cayman Islands $1.28B AUM 131.9% 1-Year Est. Return
ALSV
ATP Life Science Ventures New York $898M AUM 84.86% 1-Year Est. Return
TNB
TCF National Bank Sioux Falls, South Dakota $883M AUM 60.21% 1-Year Est. Return
FIB
First Interstate Bancsystem Billings, Montana $841M AUM

Omni Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Omni Partners held 54 positions worth $3.73M, down 100% from $1.38B the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Omni Partners withdrew a net $103M in Q4 2019, closing 12 positions and reducing 5 holdings. Its most notable exit was Celgene Corp, an estimated $243M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Omni Partners opened a new position in Medicines Co worth $196K.

  • Omni Partners's largest Q4 2019 buy was Medicines Co: 2,311,536 shares worth $196K.
  • Omni Partners added most to Wellcare Health Plans, Inc. in Q4 2019, an estimated $43.3M increase.
  • Omni Partners's biggest Q4 2019 reduction was Cypress Semiconductor, cutting an estimated $108M.
  • Omni Partners fully exited Celgene Corp in Q4 2019, selling an estimated $243M.
  • Omni Partners's ten largest holdings make up 92% of its $3.73M portfolio in Q4 2019.
  • Omni Partners opened 24 new positions and closed 12 in Q4 2019.
  • Omni Partners's portfolio value fell 100% quarter-over-quarter to $3.73M.

Based on Omni Partners's 13F filing for Q4 2019, filed 13 Feb 2020.